Navigation Links
South Asians with diabetes more likely to lose their eyesight earlier than white Europeans
Date:3/24/2009

South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition.

A UK study carried out by the University of Warwick shows diabetic retinopathy (damage to the retina) is more prevalent in South Asians and occurs earlier than in White European people with diabetes.

The study, published in the latest issue of Diabetes Care, looked at 1.035 patients with type 2 diabetes, 421 were of South Asian origin and 614 were White Europeans. The results showed 45% of South Asians had retinopathy, compared to 37% of White Europeans, and 16% of the South Asian group had sight threatening retinopathy, compared to 12% White Europeans.

South Asian diabetes patients were also significantly younger than the White European group. The average age of the South Asian group at diagnosis of diabetes was 53 years, compared to 57 years for White Europeans. The study also suggested South Asians developed diabetic retinopathy about seven years earlier than White Europeans.

This study is part of the UK Asian Diabetes Study, a randomised controlled trial designed to evaluate the benefits of an enhanced diabetes care package for people of South Asian ethnicity with type 2 diabetes in Coventry and Birmingham.

For this project, researchers collected clinical data from 10 GP practices in the Foleshill area of Coventry. Details on risk factors including blood pressure, duration of diabetes, age at onset of diabetes and cholesterol were recorded.

One of the study's authors Professor Sudhesh Kumar, Professor of Medicine, Diabetes & Endocrinology at Warwick Medical School, said the results emphasised the need for effective screening and earlier diagnosis of diabetes among the South Asian population.

He said: "The South Asian participants in this study had significantly higher systolic and diastolic blood pressures and cholesterol levels. Systematic screening for retinopathy, combined with intensive management of diabetes, including reduction of blood glucose and blood pressure, could help to reduce the incidence of visual impairment and blindness in ethnic minority groups across the world, addressing an important health inequality."

In adults, the systolic pressure should be less than 120 mmHg and the diastolic pressure should be less than 80 mmHg. In this study, the South Asian participants recorded 144 mmHg systolic pressure and 84 mmHg diastolic pressure.

Professor Kumar added: "Health care professionals in developed and developing countries need to be aware of the potential contribution of diabetic retinopathy to visual loss in South Asian communities."

Fellow author Dr Paul O'Hare, from Warwick Medical School, said: "Screening for diabetic retinopathy is becoming more systematic across the UK and the developed world. However, coverage rates and uptake among ethnic minority groups in inner city areas may be much lower than those for white Europeans. We need to address this to try and rectify these important health inequalities."


'/>"/>

Contact: Kelly Parkes-Harrison
k.e.parkes@warwick.ac.uk
44-782-454-0863
University of Warwick
Source:Eurekalert

Related medicine news :

1. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
2. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
3. DNC: South Carolina Rejecting Romneys Smooth Talk on Health Care
4. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
5. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
6. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
7. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
8. ASTRO, Wellness Community South Bay Cities Join to Promote Cancer Survivorship
9. USAID Assistant Administrator Hess Travels to Southern Africa
10. IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor
11. Medical University of South Carolina Leads Multicenter Study Evaluating Biliary Sphincter Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... ... Conference from Sept. 18 to 20. , The two-day conference is focused on ... the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. The ...
(Date:6/23/2017)... ... , ... Ross Insurance Agency ( http://www.rossinsuranceagency.com ) saves clients ... (FEMA) recent update of flood zones, more people than ever are in flood ... to reflect the actual risk in flood zone areas during a time when ...
(Date:6/23/2017)... ... June 23, 2017 , ... Jusino Insurance Services, ... communities in the greater Chicago metropolitan area, is embarking on a charity drive ... in Chicago. , Founded in 1897, Hephzibah Children’s Association is one of the ...
(Date:6/22/2017)... FL (PRWEB) , ... June 22, 2017 , ... Branches, ... received more than $245,000 in grant funding to support its programs focused on providing ... Branches, Inc. was awarded a grant by the Foundation of $15,000 to support its ...
(Date:6/22/2017)... ... June 22, 2017 , ... Children’s National Health System ... (AHA) to launch a Rheumatic Heart Disease Center, with the goal of developing ... heart disease (RHD) in high-risk, financially disadvantaged countries and low-income communities across the ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, ... healthcare, today announced that the U.S. Food and Drug Administration ... June 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning ... manufacturing facility is a measure of the progress we ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company ... from three Phase 3 studies of galcanezumab, an investigational ... including late-breaking data on several key secondary endpoints for ... results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will ... annual scientific meeting in Boston . ...
Breaking Medicine Technology: